Happy Hunting: Tyco Nellcor, Masimo Find Dual-Source Contracts Abet Sales

Tyco Nellcor looks to sustain 5% sales growth for its pulse oximetry products in the face of increasing price pressure and competition eroding the firm's more than 80% U.S. market share

More from Archive

More from Medtech Insight